MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Interim Report of Quality of Life Outcomes After Deep Brain Stimulation for Parkinson’s Disease from a Large Global Real-World Study

    A. Gharabaghi, L. Lopez, A. Schnitzler, S. Chen, L. Himes, M. Frassica, D. Nanduri, S. Groppa (Tuebingen, Germany)

    Objective: To summarize quality of life outcomes after 2 years of deep brain stimulation (DBS) for Parkinson’s disease (PD). Background: DBS improves motor fluctuations associated…
  • 2024 International Congress

    The Contribution of Cognitive and Affective Factors to Balance Control in People with Parkinson’s Disease Attending an Outpatient Clinic

    E. Spasova, C. O'Keeffe, A. Blanco-Campal, J. Inocentes, C. Fearon, R. Reilly (Dublin, Ireland)

    Objective: The central aim of this cross-sectional study is to define the cognitive and affective contributors to balance control assessment in a cohort of people…
  • 2024 International Congress

    Listening to the Insight: The Underdiagnosis of Depression in People Living with Parkinson’s Disease

    G. Rivera-Monroy, RJ. Baños-Betancourt, K. Velázquez-Román, CF. álvarez-Hernández, AL. Guerra-Anzaldo, WF. Moguel-Cardín, A. Domínguez-García, MF. Medina-Pérez, JC. Delgado-Uriarte, NP. Moreno-Aldama, A. Uribe-León, MC. Unda-Mcfarlane, AJ. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To determine the prevalence of risk of undiagnosed depression among people living with Parkinson's disease (PwP) without a prior depression diagnosis. Background: Parkinson's disease…
  • 2024 International Congress

    Incidence and Prevalence of Parkinson’s Disease Among United States Medicare Beneficiaries by Age, Sex, Race/Ethnicity, and Neighborhood Socioeconomic Status 2014-2021

    T. Rosa, S. Mantri, C. Ford, S. Soneji, B. Kaufman, F. Li, B. Grory, Y. Xian, K. Johnson, R. O’Brien, E. O’Brien, J. Lusk, B. Hammill (Durham, USA)

    Objective: To evaluate the trends and differences in incidence and prevalence of Parkison's disease (PD) in Medicare beneficiaries between 2014-2021 across different demographics. Background: The…
  • 2024 International Congress

    Cohort effects on risk scores and risk markers for Parkinson’s disease – comparison of an online-recruited versus population-based cohort

    K. Marini, C. Theyer, C. Horlings, H. Stockner, K. Schwarzová, I. Egner, A. Djamshidian-Tehrani, G. Rungger, P. Willeit, J. Willeit, S. Kiechl, M. Martì, A. Garrido, E. Tolosa, B. Mollenhauer, C. Trenkwalder, S. Schade, R. Krüger, V. Satagopam, K. Rege, S. Ghosh, T. Marques, D. Mcintyre, K. Seppi, W. Poewe, P. Mahlknecht (Innsbruck, Austria)

    Objective: To compare the distribution of Parkinson’s disease (PD) risk markers and comprehensive risk scores in an online-cohort recruited with open invitations through a media…
  • 2024 International Congress

    The Effect of Genotype on Voice & Swallowing in Parkinson’s Disease: A Parkinson’s Progression Markers Initiative Study

    M. Dumican, T. Reyers, A. Malczewski (Kalamazoo, USA)

    Objective: The objectives of this project were twofold: 1. Determine how genotypes of Parkinson’s Disease (PD) affect voice & swallowing function, and 2. Examine how…
  • 2024 International Congress

    Cross-sectional study: what is the sleep quality, daytime sleepiness and quality of life like of people with parkinson’s disease at different stages of the disease?

    G. Leveck, L. Paladini, T. Christinelli, V. Israel (CURITIBA, Brazil)

    Objective: To verify sleep quality, daytime sleepiness and quality of life in the different stages of Parkinson's disease (PD). Background: The cholinergic, noradrenergic and serotonergic…
  • 2024 International Congress

    The neural contributions to fear of falling avoidance behavior in Parkinson’s disease: preliminary evidence from a mobile neuroimaging paradigm

    C. Papantonatos, S. Carlson, YF. Chiu, N. Fritz, D. Peterson, J. Longhurst (Saint Louis, USA)

    Objective: The purpose of this study was to determine the relationship between fear of falling avoidance behavior (FFAB) and cortical hemodynamic response during dual-task (DT)…
  • 2024 International Congress

    Development and Feasibility Trial of iSupport-PD, a Digital intervention for carers of people with Parkinson’s and Cognitive Impairment

    A. Hand, J. Slodkowska-Barabasz, J. Milne, A. Mccarthy, K. Greenwell (Newcastle-upon-Tyne, United Kingdom)

    Objective: Develop a digital intervention to prevent or decrease the mental and physical health problems associated with caring and improve quality of life of carers…
  • 2024 International Congress

    Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participation

    J. Verbrugge, H. Oas, L. Cook, T. Schwantes-An, L. Walsh, T. Foroud, K. Marder, I. Mata, N. Mencacci, T. Simuni, M. Nance, M. Schwarzschild, A. Wills, S. Lawrence, A. Hall, A. Naito, J. Beck, R. Alcalay (Indianapolis, USA)

    Objective: To investigate whether participants in the PD GENEration study (NCT04994015) perceived personal benefit from receiving genetic testing for Parkinson’s disease (PD), whether being tested…
  • « Previous Page
  • 1
  • …
  • 303
  • 304
  • 305
  • 306
  • 307
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley